Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07335328
What this trial is testing

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

Who this might be right for
B-cell Non Hodgkin Lymphoma
Medical College of Wisconsin 24
Not applicableLooking for participantsNCT06222957
What this trial is testing

The Effects of HER2 Receptor Signaling on Human Brown Fat Activity

Who this might be right for
Breast Cancer
Rigshospitalet, Denmark 30
Not applicableWithdrawnNCT01831037
What this trial is testing

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
University of Arkansas
Early research (Phase 1)UnknownNCT05155839
What this trial is testing

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
Shanghai Miracogen Inc. 108
Testing effectiveness (Phase 2)Ended earlyNCT04683939
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Who this might be right for
Solid TumorGastric CancerGastroesophageal Junction Adenocarcinoma+5 more
BioNTech SE 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 194
Not applicableUnknownNCT04203459
What this trial is testing

The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation

Who this might be right for
Pancreatic CancerGut MicrobiotaCAR-T
First Affiliated Hospital of Harbin Medical University 80
Not applicableLooking for participantsNCT06902623
What this trial is testing

Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

Who this might be right for
Oropharyngeal CancersHPVTonsil Cancer+1 more
Georgetown University 30
Early research (Phase 1)Study completedNCT02561962
What this trial is testing

Study in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 42
Not applicableStudy completedNCT01366157
What this trial is testing

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 23
Not applicableLooking for participantsNCT06815939
What this trial is testing

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Who this might be right for
Human Papillomavirus (HPV)Cervical Intraepithelial NeoplasiaUterine Cervical Neoplasms+1 more
DL Analytics 10,000
Early research (Phase 1)Study completedNCT02285101
What this trial is testing

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

Who this might be right for
MelanomaProstate Adenocarcinoma
Bio-Cancer Treatment International Limited 23
Large-scale testing (Phase 3)Study completedNCT02750202
What this trial is testing

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Who this might be right for
Genital Warts
University of Pretoria 52
Early research (Phase 1)Looking for participantsNCT06879041
What this trial is testing

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
AstraZeneca 136
Not applicableStudy completedNCT06463626
What this trial is testing

Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

Who this might be right for
Hormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Novartis 121
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Not applicableUnknownNCT05376943
What this trial is testing

Possible Differences in HCC Course Depending on DAA Treatment

Who this might be right for
Carcinoma, HepatocellularHepatitis C Virus Infection, Response to Therapy ofDrug Effect+3 more
Medical University of Warsaw 100
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Not applicableStudy completedNCT00339326
What this trial is testing

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

Who this might be right for
Kaposi's Sarcoma
National Cancer Institute (NCI) 1,383
Next Page